CLINICAL_TRIALS
trial_result
· 2013-06-20
Clinical Trial Update: Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Phase 3]
Summary
Phase 3 trial evaluating zoledronic acid for chemotherapy-induced bone loss completed; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Non-Hodgkin's Lymphoma, Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2013-06-20